Successful pre-clinical testing of QuickMIC® in the US
Today we announce the successful completion of our pre-clinical testing of the QuickMIC® system in the US. The evaluation of our QuickMIC® system showed excellent performance and holds promises for the upcoming FDA study. Results from the US pre-clinical study will be presented at significant microbiology conferences during the next year.
This pre-clinical testing included about a hundred clinical patient samples and was performed at two reputable US clinical laboratories.
Next-generation antimicrobial susceptibility testingTake a look at our E-book